Smart patch could spot silent killer in kidney patients without needles

NCT ID NCT07054905

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a small, chest-worn ECG device can detect high potassium levels (hyperkalemia) in people with chronic kidney disease undergoing dialysis. Thirty-two patients wore the device during dialysis sessions, and the ECG readings were compared with blood test results. The goal is to find a non-invasive way to spot dangerous potassium spikes early, potentially reducing the need for frequent blood draws and improving patient safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HiCardi wearable ECG device
What this could lead to
If successful, this could lead to a non-invasive way to monitor potassium levels in dialysis patients, reducing the need for frequent blood draws and enabling earlier intervention.
What could go wrong
This is a small, completed observational study with only 32 participants. The results may not apply to all dialysis patients, and the device's accuracy needs confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chungnam National University Hospital

    Daejeon, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.